Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Anne Phillips

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Current Opinion in Obstetrics & Gynecology|December 16, 2014
Clinical management of women at high risk of breast cancerMelanie Wuttke, Kelly-Anne Phillips
Best Practice & Research. Clinical Obstetrics & Gynaecology|August 29, 2018
Conservative management of reproductive cancers. Ovarian protection during treatmentWanyuan Cui, Kelly-Anne Phillips
Expert Review of Anticancer Therapy|August 31, 2017
Genetic testing in women with breast cancer: implications for treatmentRobin Paterson, Kelly-Anne Phillips
Journal of the National Cancer Institute|February 6, 2003
Adjuvant breast cancer treatment and cognitive function: current knowledge and research directionsKelly-Anne Phillips, Jürg Bernhard
JAMA|December 12, 2025
Unlocking the Potential of Risk-Based Screening for Breast Cancer: From Detection to PreventionNancy N Baxter, Kelly Anne Phillips
Future Oncology (London, England)|April 24, 2014
Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?Kelly-Anne Phillips, Geoffrey J Lindeman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2022
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women With Germline <i>BRCA</i> Pathogenic Variants: A Cause for Concern or Potentially Avoidable?Kelly-Anne Phillips, Michael L Friedlander
Cancer Treatment and Research Communications|January 6, 2022
Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observationOmali Pitiyarachchi, Kelly-Anne Phillips, Michael Friedlander
Breast Cancer Research : BCR|March 12, 2011
Do aromatase inhibitors have adverse effects on cognitive function?Kelly Anne Phillips, Karin Ribi, Richard Fisher
JAMA Oncology|July 1, 2021
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution NeededCiara Conduit, Roger L Milne, Kelly-Anne Phillips
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Current Opinion in Obstetrics & Gynecology|December 16, 2014
Clinical management of women at high risk of breast cancerMelanie Wuttke, Kelly-Anne Phillips
Best Practice & Research. Clinical Obstetrics & Gynaecology|August 29, 2018
Conservative management of reproductive cancers. Ovarian protection during treatmentWanyuan Cui, Kelly-Anne Phillips
Expert Review of Anticancer Therapy|August 31, 2017
Genetic testing in women with breast cancer: implications for treatmentRobin Paterson, Kelly-Anne Phillips
Journal of the National Cancer Institute|February 6, 2003
Adjuvant breast cancer treatment and cognitive function: current knowledge and research directionsKelly-Anne Phillips, Jürg Bernhard
JAMA|December 12, 2025
Unlocking the Potential of Risk-Based Screening for Breast Cancer: From Detection to PreventionNancy N Baxter, Kelly Anne Phillips
Future Oncology (London, England)|April 24, 2014
Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?Kelly-Anne Phillips, Geoffrey J Lindeman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2022
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women With Germline <i>BRCA</i> Pathogenic Variants: A Cause for Concern or Potentially Avoidable?Kelly-Anne Phillips, Michael L Friedlander
Cancer Treatment and Research Communications|January 6, 2022
Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observationOmali Pitiyarachchi, Kelly-Anne Phillips, Michael Friedlander
Breast Cancer Research : BCR|March 12, 2011
Do aromatase inhibitors have adverse effects on cognitive function?Kelly Anne Phillips, Karin Ribi, Richard Fisher
JAMA Oncology|July 1, 2021
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution NeededCiara Conduit, Roger L Milne, Kelly-Anne Phillips
Pageof 16